Quest Laboratories
Ticker > Company >

Quest Laboratories share price

Quest Laboratories Ltd.

NSE: QUESTLAB SECTOR: Pharmaceuticals & Drugs  8.86 K   27   1

128.60
-5.75 (-4.28%)
NSE: 13 Feb 03:53 PM

Price Summary

Today's High

₹ 135.5

Today's Low

₹ 125

52 Week High

₹ 145.95

52 Week Low

₹ 75.15

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 210.74 Cr.

Enterprise Value

₹ 240.88 Cr.

No. of Shares

1.64 Cr.

P/E

15.53

P/B

2.34

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  54.88

CASH

₹ 0.11 Cr.

DEBT

₹ 30.26 Cr.

Promoter Holding

66.78 %

EPS (TTM)

₹  8.28

Sales Growth

25.92%

ROE

24.56 %

ROCE

26.87%

Profit Growth

34.4 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year25.92%
3 Year20.46%
5 YearNA

Profit Growth

1 Year34.4%
3 Year48.95%
5 YearNA

ROE%

1 Year24.56%
3 Year36.97%
5 Year34.74%

ROCE %

1 Year26.87%
3 Year43.64%
5 Year39.64%

Debt/Equity

0.3699

Price to Cash Flow

-9.03

Interest Cover Ratio

21.6341

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2025 66.78 0.00
Sep 2025 66.78 0.00
Mar 2025 66.21 0.00
Dec 2024 65.83 0.00
Sep 2024 65.83 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 48.9534221729903% for the Past 3 years.
  • The company has shown a good revenue growth of 20.4563076668604% for the Past 3 years.
  • Company has been maintaining healthy ROE of 36.9650666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 43.6397666666667% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 21.6341.
  • Company has a healthy liquidity position with current ratio of 2.8767.
  • The company has a high promoter holding of 66.78%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.58371427393854.

 Limitations

  • Company has negative cash flow from operations of -23.3254.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025
Net Sales 23.19 25.62
Total Expenditure 19.37 22.23
Operating Profit 3.81 3.39
Other Income 1.86 1.42
Interest 0.64 0.58
Depreciation 0.21 0.21
Exceptional Items 0 0
Profit Before Tax 4.83 4.02
Tax 0.72 0
Profit After Tax 4.11 4.02
Adjusted EPS (Rs) 2.51 2.45

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 30.36 59.48 61.64 82.56 103.97
Total Expenditure 28.95 53.02 53.8 67 87.98
Operating Profit 1.42 6.47 7.84 15.56 15.98
Other Income 0.07 0.06 0.23 0.23 4.24
Interest 0.31 0.3 0.54 0.78 0.91
Depreciation 0.39 0.46 0.55 0.57 0.64
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.79 5.77 6.98 14.45 18.68
Tax 0.13 1.66 1.94 4.35 5.12
Net Profit 0.66 4.11 5.04 10.09 13.57
Adjusted EPS (Rs.) 0.61 3.81 4.68 8.46 8.28

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 1.08 1.08 1.08 11.94 16.39
Total Reserves 4.81 8.91 14.02 16.73 65.42
Borrowings 1.15 1.33 1.88 0.9 1.36
Other N/C liabilities 0.4 0.53 0.62 0.77 1.31
Current liabilities 10.95 22.94 29.35 30.2 37.18
Total Liabilities 18.4 34.8 46.94 60.54 121.65
Assets
Net Block 5.94 7.38 9.84 10.24 11.79
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.09 0.09 0.09 0 2.92
Loans & Advances 0.29 0.5 3.04 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 12.08 26.84 33.98 50.3 106.95
Total Assets 18.4 34.8 46.94 60.54 121.65
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 0.79 5.77 6.98 14.45 18.68
Adjustment 0.75 0.74 0.86 1.1 -2.69
Changes in Assets & Liabilities -0.08 -2.78 -2.17 -8.33 -35.23
Tax Paid -0.41 -0.27 -1.79 -4.21 -4.09
Operating Cash Flow 1.05 3.46 3.88 3.01 -23.33
Investing Cash Flow -1.2 -1.89 -3.82 -5.03 -43.97
Financing Cash Flow 0.04 -0.41 0 2.04 67.26
Net Cash Flow -0.11 1.15 0.06 0.02 -0.03

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Dec 2024% Mar 2025% Sep 2025% Dec 2025%
promoters 65.83 65.83 66.21 66.78 66.78
anil kumar sabarwal 62.04 62.04 62.29 62.80 62.80
tejaswini sabarwal 2.48 2.48 2.55 2.59 2.59
vinayak sabarwal 1.30 1.30 1.37 1.40 1.40
PARTICULARS Sep 2024% Dec 2024% Mar 2025% Sep 2025%
investors 34.17 34.17 33.79 33.22
harsha venkatesh - - - 1.47
kamlesh chandulal gandhi 1.24 1.24 1.22 1.22
priti kamlesh gandhi 1.22 1.22 1.22 1.22
sandeep singh - - - 1.08
yashvi hitesh patel - - - 1.79
sandeep singh - - 1.07 -
ankush kedia 1.83 1.83 - -
caifu investment advisory... 1.14 1.14 - -
mayuri shripal vora 1.19 1.19 - -
persistent growth fund-va... 3.68 3.68 - -

Annual Reports

Title Link
Title Link
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q2FY25
Presentation Q2FY25

Quest Laboratories Stock Price Analysis and Quick Research Report. Is Quest Laboratories an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Quest Laboratories. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Quest Laboratories has a PE ratio of 15.5338398540834 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Quest Laboratories has ROA of 14.8929% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Quest Laboratories has a Current ratio of 2.8767.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Quest Laboratories has a ROE of 24.5607%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Quest Laboratories has a Debt to Equity ratio of 0.3699 which means that the company has low proportion of debt in its capital.

  • Sales growth: Quest Laboratories has reported revenue growth of 25.9233% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Quest Laboratories for the current financial year is 15.372266649225%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Quest Laboratories is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Quest Laboratories is Rs 8.2787. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Quest Laboratories in Ticker for free. Also, one can get the intrinsic value of Quest Laboratories by using Valuation Calculators, which are available with a Finology ONE subscription. 

Quest Laboratories FAQs

Q1. What is Quest Laboratories share price today?
Ans: The current share price of Quest Laboratories is Rs 128.6.

Q2. What is the market capitalisation of Quest Laboratories?
Ans: Quest Laboratories has a market capitalisation of Rs 210.739392 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Quest Laboratories?
Ans: The PE ratio of Quest Laboratories is 15.5338398540834 and the P/B ratio of Quest Laboratories is 2.3434951608465, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Quest Laboratories share?
Ans: The 52-week high share price of Quest Laboratories is Rs 145.95, and the 52-week low share price of Quest Laboratories is Rs 75.15.

Q5. Does Quest Laboratories pay dividends?
Ans: Currently, Quest Laboratories does not pay dividends. Dividend yield of Quest Laboratories is around 0%.

Q6. What are the face value and book value of Quest Laboratories shares?
Ans: The face value of Quest Laboratories shares is Rs 10, while the book value per share of Quest Laboratories is around Rs 54.8753. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Quest Laboratories?
Ans: Quest Laboratories has a total debt of Rs 30.2578 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Quest Laboratories?
Ans: The ROE of Quest Laboratories is 24.5607% and ROCE of Quest Laboratories is 26.8692%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Quest Laboratories a good buy for the long term?
Ans: The Quest Laboratories long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Quest Laboratories undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Quest Laboratories appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Quest Laboratories’s financials?
Ans: You can review Quest Laboratories’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Quest Laboratories
X